PR Campaign Award
Entry criteria
This category covers ongoing work or one-off projects undertaken between December 2008 and December 2009 by or on behalf of a pharmaceutical company relating to TGA approved medications at any stage in a product lifecycle (also includes those currently seeking approval).
This category recognises best practice in pharmaceutical product communications. Judges will be looking for:
- Responsible programs that deliver effective communications for the company and the product in an appropriate manner, together with clear benefits for stakeholders
- Programs that ensure appropriate awareness, knowledge, and use of products that improve understanding of, and trust in, the company and product, and deliver improvements in healthcare.
Format & Guidelines
The entry should be a submission of 1500 – 3000 words, together with an executive summary or synopsis of 500 words and any supporting materials. It should cover the following areas:
- Clearly defined strategy
- Clarity of objectives and identification of the audience group
- Careful targeting of media, or other channel, as appropriate
- Creativity or innovation in content, presentation or approach
- How well the program identified and delivered specific and appropriate key messages for the intended audience
- Effectiveness – evidence for and measurement of successful outcomes set against key objectives
Note: Entries and supporting material should be unbound. Please supply 4 copies of all supporting materials
Short listed entries will be given the opportunity to submit a "poster" summary of their campaign to be included in the exhibition of winners work at the PRIME Awards ceremony. If your entry is short listed, you will be notified by email in August 2010.
Winners will be announced at the awards ceremony on Thursday 23 September 2010.
If you would like to make a submission for this award category, please review information on 'How To Enter' page and proceed with completing the 'Entry Form'.
Should you have any further questions regarding this category, please send an e-mail to This e-mail address is being protected from spambots. You need JavaScript enabled to view it
| Next > |
|---|
